Abstract
Objective: To discuss the importance of early detection and health promotion strategies, focusing on public awareness to reduce breast cancer mortality. Methods: A documentary study used quantitative data from DATASUS. The study analyzed breast cancer mortality records between 2020 and 2023. Data were organized in tables and graphs, considering sex, age group, and annual death numbers. Results: There was a progressive increase in breast cancer deaths among women from 2020 to 2023, with the highest rate in 2023. João Pessoa and Campina Grande showed the highest mortality rates. Most deaths occurred among people aged 50 to 69 years. Despite the low incidence, male deaths were also recorded, mainly in João Pessoa. Conclusion: The increase in breast cancer mortality suggests reduced screening effectiveness, possibly due to delays caused by the COVID-19 pandemic. The findings reinforce the need to expand screening and health education strategies. The lack of integration between academic activities and municipal health policies, combined with cultural barriers and lack of information, contributes to late diagnosis, especially among men.
References
ALMEIDA MR. Aplicação de algoritmos de inteligência artificial em programas de rastreamento mamográfico no Nordeste brasileiro. Revista Brasileira de Cancerologia, 2024; 70(2):154–162.
BARCELOS MR, et al. Utilização de mamografia e desigualdades regionais no Brasil: estudo ecológico nacional. Revista de Saúde Pública, 2022.
COSTA AC, et al. Screening and hospitalization of breast and cervical cancer in Brazil (2010–2022). PLOS ONE, 2024; 19(6): e0298461.
COSTA LA, et al. Tendências temporais da mortalidade por câncer de mama no Nordeste do Brasil (2010–2023). Revista Brasileira de Epidemiologia, 2024.
HYEDA A, et al. The Negative Impact of the COVID-19 Pandemic on Breast Cancer Care in Brazil: time series study between 2014 e 2022. BMC Health Services Research, 2024; p.11769.
HYEDA A, et al. Integrating health education and breast cancer screening in medical curricula: Evidence from community-based programs in Brazil. Revista Brasileira de Educação Médica, 2024.
INSTITUTO NACIONAL DE CÂNCER (INCA). Parâmetros técnicos para o rastreamento do câncer de mama. Rio de Janeiro: INCA; 2021.
OLIVEIRA DS, et al. Barriers and facilitators for opportunistic mammography screening in Brazil. BMC Public Health, 2025; 25:1–12.
ROCHA AFBM, et al. COVID-19 and Breast Cancer in Brazil. International Journal of Public Health, 2023; 1605485.
ROCHA CF, et al. Perfil epidemiológico do câncer de mama em Pernambuco e fatores associados à mortalidade feminina. Cadernos Saúde Coletiva, 2023.
SALA DCP, et al. Barriers and facilitators of the implementation of mammography screening in the Brazilian public health system: scoping review. BMC Public Health, 2025; 25(1):1659.
SANTOS EF, et al. Social inequalities in access to cancer screening and early detection: a population-based study in the city of São Paulo, Brazil. Clinics (São Paulo), 2023; 78:e4135.
SANTOS LM, et al. Análise epidemiológica dos protocolos de rastreamento e tratamento do câncer de mama no contexto brasileiro. Clinical Oncology Letters, 2025; 2(1):10–25.
SILVA RCF, HORTALE VA. Rastreamento do câncer de mama no Brasil: quem, como e por quê? Revista Brasileira de Cancerologia, 2022; 68(3):e-11238.
SILVA S, HORTALE VV. Vínculo entre formação médica e vigilância em saúde: desafios da integração ensino-serviço. Ciência & Saúde Coletiva, 2022.
SOUSA MA, et al. Barreiras geográficas e adesão terapêutica no tratamento do câncer de mama no Nordeste brasileiro: análise multicêntrica entre Paraíba, Pernambuco e Ceará. Revista Brasileira de Oncologia e Saúde Coletiva, 2024; 16(2):145–158.
UNIVERSIDADE FEDERAL DA PARAÍBA (UFPB). Educação em saúde sobre câncer de mama: relato de experiência com estudantes de Medicina. Revista de Extensão em Saúde, 2024; 3(1):55–61.
VIEIRA FM, et al. Inovação tecnológica e formação médica: impactos da digitalização na Atenção Primária à Saúde. Interface (Botucatu), 2024; 28:e230121.
